Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer

Data in Brief

Jeffrey P. Hammel¹  Dan P. Gaile²  Zachary A.P. Wintrob³  Alice C. Ceacareanu³  George K. Nimako³  Alan Forrest⁴ 

[1] Cleveland Clinic, Dept. of Biostatistics and Epidemiology, 9500 Euclid Ave., Cleveland, OH 44195, United States;State University of New York at Buffalo, Dept. of Biostatistics, 718 Kimball Tower, Buffalo, NY 14214, United States;State University of New York at Buffalo, Dept. of Pharmacy Practice, NYS Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United States;The UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, Campus Box 7569, Chapel Hill, NC 27599, United States;

关键词: Growth factor;    EGF;    FGF;    PDGF;    HGF;    TGF;    VEGF;    Insulin;    Breast cancer;    Diabetes;    Cancer outcomes;    Cancer prognosis;   

DOI  :  10.1016/j.dib.2017.02.017

来源: DOAJ

【 摘 要 】

Growth factor profiles could be influenced by the utilization of exogenous insulin. The data presented shows the relationship between pre-existing use of injectable insulin in women diagnosed with breast cancer and type 2 diabetes mellitus, the growth factor profiles at the time of breast cancer diagnosis, and subsequent cancer outcomes. A Pearson correlation analysis evaluating the relationship between growth factors stratified by of insulin use and controls is also provided.

【 授权许可】

Unknown